advantages of using car-nks for the treatment of hematological malignancies
Published 2 years ago • 100 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
4:20
an insight into the use of car-nks for the treatment of aml
-
2:56
car-nk clinical trials
-
3:18
allogeneic car-nk cell therapy in r/r aml/mds
-
8:54
ft596: ipsc-derived car-nk cells with engineered persistence for b-cell malignancies
-
1:03
addressing car-nk unknowns
-
1:19
car-t vs car-nk for myeloma
-
2:06
nk car-based therapies & future perspectives
-
5:35
advanced flow cytometry & car-t for the treatment of acute leukemias
-
0:40
the current status of car t and car nk cells in multiple myeloma
-
4:25
exciting developments in the car space: novel target antigens, car-nks & switchable car-ts
-
1:08
the benefits of car-t therapy in 2l over 3l in r/r dlbcl
-
1:17
nk-car immunotherapy: the next steps
-
1:49
are car nk-cells the future of cll therapy?
-
1:26
ebmt guidelines car-t education & guidelines for nurses
-
3:21
rationale for nk-cell therapy in myeloma
-
2:43
car-nk and car-t for mcl
-
1:28
future prospects for nk cell therapy
-
1:30
insights into nkg2d-targeting car-t cells in r/r aml
-
3:02
nk-car immunotherapy development over the past 12 months